APA (7th ed.) Citation

Clemente-González, C., & Carnero, A. (2025). Tfcp2l1 as a central integrator of hypoxia, dedifferentiation, and tumor progression. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03501-9

Chicago Style (17th ed.) Citation

Clemente-González, Cynthia, and Amancio Carnero. "Tfcp2l1 as a Central Integrator of Hypoxia, Dedifferentiation, and Tumor Progression." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03501-9.

MLA (9th ed.) Citation

Clemente-González, Cynthia, and Amancio Carnero. "Tfcp2l1 as a Central Integrator of Hypoxia, Dedifferentiation, and Tumor Progression." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03501-9.